OICR offers a number of funding opportunities for Ontario researchers throughout the year to help enable world-class cancer research across the province.
Cancer Therapeutics Innovation Pipeline – Request for applications
The Cancer Therapeutics Innovation Pipeline (CTIP) Program was established to capitalize on Ontario’s expertise in cancer biology and drug discovery. Its aim is to create a pipeline of validated cancer targets and first-in-class or best-in-class, novel, selective lead molecules (small molecules or biologics) that will attract partnerships and/or investment for further preclinical and clinical development. To generate a sustainable pipeline, CTIP will support projects that aim to provide increasing evidence of target validation and disease association using data from knowledge bases, functional assays, and drug screening in relevant in vitro and in vivo models of the cancer type of interest.
OICR Innovation to Implementation Supplement
The full application deadline has now passed for this funding opportunity
The Ontario Institute for Cancer Research (OICR) is inviting applications for the Innovation to Implementation Supplement (I2IS), which is focused on overcoming barriers to the mobilization, or uptake, of knowledge required to inform adoption of OICR research assets into policy or health care. OICR is committed to providing research funding to help support a sustainable health system that enables fair and equitable access to cancer interventions. I2IS is a supplement for OICR research projects supported within the last five years to move them from an experimental phase towards clinical use.
Subscribe for New Opportunities
Only active opportunities are listed here. To be notified of new opportunities, please subscribe to our mailing list.